Outpatient treatment of acute poisonings in Oslo: poisoning pattern, factors associated with hospitalization, and mortality by Lund, Cathrine et al.
ORIGINAL RESEARCH Open Access
Outpatient treatment of acute poisonings in Oslo:
poisoning pattern, factors associated with
hospitalization, and mortality
Cathrine Lund
1*, Odd M Vallersnes
2,3, Dag Jacobsen
1, Oivind Ekeberg
1 and Knut E Hovda
1,4
Abstract
Background: Most patients with acute poisoning are treated as outpatients worldwide. In Oslo, these patients are
treated in a physician-led outpatient clinic with limited diagnostic and treatment resources, which reduces both
the costs and emergency department overcrowding. We describe the poisoning patterns, treatment, mortality,
factors associated with hospitalization and follow-up at this Emergency Medical Agency (EMA, “Oslo Legevakt”), and
we evaluate the safety of this current practice.
Methods: All acute poisonings in adults (> or = 16 years) treated at the EMA during one year (April 2008 to April
2009) were included consecutively in an observational study design. The treating physicians completed a
standardized form comprising information needed to address the study’s aims. Multivariate logistic regression
analysis was used to identify the factors associated with hospitalization.
Results: There were 2348 contacts for 1856 individuals; 1157 (62%) were male, and the median age was 34 years.
The most frequent main toxic agents were ethanol (43%), opioids (22%) and CO or fire smoke (10%). The
physicians classified 73% as accidental overdoses with substances of abuse taken for recreational purposes, 15% as
other accidents (self-inflicted or other) and 11% as suicide attempts. Most (91%) patients were treated with
observation only. The median observation time until discharge was 3.8 hours. No patient developed sequelae or
died at the EMA. Seventeen per cent were hospitalized. Gamma-hydroxybutyric acid, respiratory depression,
paracetamol, reduced consciousness and suicidal intention were factors associated with hospitalization. Forty-eight
per cent were discharged without referral to follow-up. The one-month mortality was 0.6%. Of the nine deaths, five
were by new accidental overdose with substances of abuse.
Conclusions: More than twice as many patients were treated at the EMA compared with all hospitals in Oslo.
Despite more than a doubling of the annual number of poisoned patients treated at the EMA since 2003, there
was no mortality or sequelae, indicating that the current practice is safe. Thus, most low- to intermediate-acuity
poisonings can be treated safely without the need to access hospital resources. Although the short-term mortality
was low, more follow-up of patients with substance abuse should be encouraged.
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Efficiency and cost control are both universal political
health goals. In Norway, one approach is to treat
patients at the lowest health care level possible without
impairing the quality of the treatment. Recognizing and
hospitalizing high-risk patients are crucial to an effective
system.
Acute poisoning is considered a major health problem
worldwide and is a frequent cause of hospital admission.
Most patients are managed as outpatients in hospital
emergency departments. In Scandinavia, however,
patients presenting with poisoning by substances of
abuse, especially heroin overdose, are frequently dis-
charged by the ambulance service without transfer to
hospital. Oslo has a long tradition of treating acute poi-
soning by substances of abuse in a unique outpatient
clinic, the Emergency Medical Agency (EMA, “Oslo
Legevakt”). This physician-led walk-in clinic has served
the entire city 24 hours a day, seven days a week since
1900 and treats low- to intermediate-acuity patients
who would otherwise present to hospital emergency
departments. Although similar in many ways to an
emergency department, the EMA is not hospital based.
Because the diagnostic tools and treatment options are
limited, treatment at the EMA is less resource consum-
ing than in-hospital treatment of equivalent conditions.
Ambulance paramedics triage patients to hospital
emergency departments or the EMA based on the
patient’s clinical condition. Low-acuity patients present-
ing directly to hospital emergency departments are often
referred to the EMA for initial evaluation. Patients are
often assessed at the EMA before hospital admission,
giving the clinic a gatekeeping function for hospital
emergency departments. We are not aware of similar
clinics, and a comprehensive literature search did not
reveal reports of equivalent treatment units.
The EMA provides treatment for poisoning by sub-
stances of abuse, and the poisoning pattern here reflects
the most frequent and dangerous substances of abuse
presently in use [1]. In 2003, the EMA treated the same
number of acute poisonings as all Oslo Hospitals in
total, the mortality was zero and most patients were dis-
charged after a short observation period [2].
Although the low-level care at the EMA is efficient, it
is important to avoid adversely affecting patient safety.
Evaluating the mortality at the EMA and after discharge
may have implications in terms of deciding whether to
discontinue or expand the current practice. If the low-
level care provided at the EMA is safe, this may identify
ways for more efficient handling of these patients in
emergency departments. Because poisoning patterns
change with time, updated information about poisoning
trends is important for clinicians and for establishing
preventive initiatives. The mortality rates 10 and 20
years after acute poisoning are alarmingly high, reflect-
ing the importance of adequate follow-up initiatives
[3,4]. Referral to follow-up after treatment at the EMA
has not been studied, and it is unknown whether the
current practice is adequate.
The study objectives were (1) to describe all acutely
poisoned adults presenting at the EMA in one year
beginning in April 2008 by collecting data on the number
of patients, toxic agents, evaluated intention and compli-
cations; (2) to evaluate the treatment given and to iden-
tify factors associated with hospitalization and referral to
follow-up; and (3) to discuss whether treatment of acute
poisonings at the EMA may be considered safe with
respect to mortality at the EMA and after one month.
Methods
Study Design
This study was part of a larger observational cross-sec-
tional multicentre study conducted from 15 April 2008
to 14 April 2009 at the EMA, the five hospitals in Oslo
that treat poisoned patients and the Institute of Forensic
Medicine. The aim was to obtain an updated complete
epidemiological picture of acute poisonings in the City
of Oslo, the Municipality of Oslo, Norway. This paper
presents data from the EMA. Data on the hospitalized
patients (n = 1069) will be published separately (Lund
C, Teige B, Drottning P, Stiksrud B, Rui TO, Lyngra M,
Ekeberg O, Jacobsen D, Hovda KE: A one year observa-
tional study of all hospitalized and fatal acute poisonings
in Oslo, submitted). The study was designed similar to a
study conducted in 2003 with the intention of compar-
ing results [2,5,6].
Ethics
The study was approved by both the Norwegian Regio-
nal Ethics Committee and the National Data Inspecto-
rate. Studying intoxicated patients is difficult from many
perspectives, including acquiring written consent,
because of the nature of the patients’ behaviour and
physical conditions. The study subjects were informed
about the aims of the study and were given a written
information leaflet with the name and phone number of
the study coordinator. They were also given the right to
refuse participation or to withdraw consent at any time
without reprisal. Thereafter, their verbal consent was
confirmed by the independent interviewing physician in
a specific question included in the standardized inter-
view form (described below).
Setting
The study was performed at the EMA, an outpatient
clinic serving the entire city 24 hours a day, seven days
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nearest hospital. The clinic is similar to an emergency
department, but has limited resources (e.g., gastric
decontamination and intubation are not performed,
a n dn ob l o o dg a sa n a l y s i se q u ipment is available). All
patients are attended by physicians, and the observa-
tion limit is 24 hours. The physicians working at the
EMA are general practitioners, mainly with a level of
training comparable to hospital residents. In contrast
to other outpatient walk-in clinics, the EMA also
receives patients from ambulances. Ambulance para-
medics triage patients to the EMA or hospital emer-
gency departments. In cases of opioid overdoses,
however, paramedics may administer naloxone on site
without further transfer [2,7]. There are no standard
triage criteria. This decision is based on an evaluation
of the patient’s clinical condition, knowledge of the
toxic agents and the treatment options at the EMA. In
general, stable patients likely to require observation for
< 24 hours and likely not to require hospital treatment
(e.g., with N-acetylcysteine, flumazenil, gastric deconta-
mination, intubation or thorough laboratory testing)
are brought to the EMA. Patients with symptoms and
history of gamma-hydroxybutyric acid poisoning are
usually hospitalized. Coma is a strong triage parameter
for hospital admission unless it is caused by substances
of abuse. The current principle is to treat patients at
the lowest treatment level possible while still providing
adequate care.
Oslo is the capital of Norway. The city area is 454
km
2, and as of July 2008 the population was 568 809, of
whom 466 423 were ≥ 16 years. The unemployment
rate in Oslo was 2.2% in 2008 [8]. In terms of gross
domestic product per capita, the World Bank ranked
Norway as the fifth highest country in 2008 [9]. Drug
and alcohol policies are strict in Norway. Alcohol is
restricted and taxed heavily. Only the Wine and Spirits
Monopoly may sell beverages exceeding 4.75% ethanol
content, and off-license sales close at 8 pm on weekdays
and 6 pm on Saturdays. Cannabis and other non-pre-
scription substances of abuse are illegal. There is a
methadone/buprenorphine maintenance programme for
heavy users of opioids. The EMA is part of the National
Public Health Care.
Selection of Participants
All adults (≥ 16 years) presenting at the EMA with a
primary diagnosis of acute poisoning were included con-
secutively. Because laboratory testing is not performed
routinely at the EMA, inclusion was based on a clinical
diagnosis of acute poisoning. Poisonings were defined as
exposure to substances in assumed toxic amounts.
Chronic poisonings were not included.
Methods of Measurement, Data Collection and Processing
All physicians at the EMA participated in the data col-
lection. All evaluations were made by the treating physi-
cian who completed a standardized form that included
information to satisfy all of the study objectives. The
study coordinator manually cross-checked the forms
against the electronic patient list to ensure that all
patients meeting the criteria were included. In the few
cases where patients had either left the EMA or had
been transferred to hospital before a form was com-
pleted, a form was completed based on the electronic
medical journal. This journal was also used as a supple-
ment where variables were missing. Missing variables
w e r ec o d e da su n k n o w na n de x c l u d e df r o mt h a tp a r t i -
cular analysis. Some patients had two contacts on the
same day for the same toxic agent. In these cases, only
the first of the contacts was included.
The data were entered manually into an SPSS spread-
sheet and checked systematically for errors. Ten per
cent of the variables were cross-checked randomly with
the original forms, and this cross-check showed 99.94%
consistency.
Outcome Measures
In patients exposed to more than one substance, the
main toxic agent was defined as the substance suspected
to be the most toxic in the amount assumed taken. This
was the treating physician’s clinical evaluation based on
the information available including statements from the
patient, companions, ambulance service, clinical obser-
vations or laboratory findings. Substances presumed to
be less toxic were registered as co-agents. Carbon mon-
oxide (CO) poisoning was classified as either CO/fire
smoke or CO/engine smoke poisoning. Complications
were defined according to standard clinical definitions
similar to those used in the 2003 study [5]. Conscious-
ness was measured on presentation and analysed as a
categorical value. Coma was defined as < 8 on the Glas-
gow Coma Scale (GCS) and drowsiness as GCS 8-14.
The intention behind the act of poisoning was evalu-
ated by the treating physician. Poisonings with sub-
stances of abuse, including heroin and ethanol for
recreational purposes, were classified as accidental over-
doses with substances of abuse (AOSAs). Suicidal moti-
vation in the act of poisoning was classified as either a
possible or definite suicide attempt. This distinction was
based on whether the patient considered the toxic agent
lethal and whether other measures had been taken to
ensure a lethal outcome. If the motive was ambivalent
(e.g., by seeking help shortly after ingestion), the poison-
ing was classified as a possible suicide attempt. No
objective scales were used for this evaluation. Accidents
included both external causes of poisoning and self-
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where the agent had been taken for neither self-harm
nor intoxication purposes.
Causes of death were obtained from the National
Death Register. Fatalities within one month after the
patient’s last contact and after every contact were
registered.
Statistics
Pearson’sc h i - s q u a r eo rF i s h e r ’s exact test (cell values <
5) was used to compare frequencies. Age comparisons
were made using the Mann-Whitney U test.
Univariate and multivariate logistic regression were
used to identify clinical patient characteristics associated
with hospital admission. Because we wanted to evaluate
the physicians’ decision making in treating the toxicologi-
cal emergency, patients either transferred to a psychiatric
ward or leaving against medical advice were excluded
from this particular analysis. All variables included in the
multivariate models were clinically relevant and had a p-
value < 0.20 in the univariate analysis. The assumptions
underlying multivariate logistic regression analyses were
checked and found to be adequately fulfilled.
Univariate logistic regression was also used to analyse
the association between the intentions behind the poi-
sonings and the six major referral endpoints: hospitaliza-
tion, transfer to a psychiatric ward, psychiatric
outpatient treatment, other follow-up (including to a
general practitioner, addiction clinic, emergency social
services and other specialists), no referral and those
leaving against medical advice. Only patients with
unknown intention were excluded from this particular
analysis.
In the calculation of short-term mortality, hospitalized
patients were excluded because we wanted to calculate
the mortality after treatment at the EMA. Hospitalized
patients and those with missing social security number
or permanent residence outside Norway were excluded;
this reduced the numbers checked against the National
Death Register to 1799/2348 contacts in 1410/1856
patients. Findings with p-values < 0.05 were considered
significant. SPSS 16.0 (SPSS Inc., Chicago, IL, USA) was
used to analyse the data.
Results
Of 2401 adults presenting at the EMA with an acute
poisoning, 53 (2.2%) refused participation. These
patients did not differ significantly from the studied
population in terms of age, sex, intention and main
toxic agents. Of the 17 patients with two contacts on
t h es a m ed a yb e c a u s eo ft h es a m et o x i ca g e n t ,f i v eh a d
left against medical advice during the first contact, and
four of the second contacts had resulted in a higher
level of follow-up.
There were 2348 poisoning episodes in 1856 indivi-
duals (Table 1). Of these individuals, 1157 (62%) were
male. The median age was 34 years (range 16-96) over-
all: 37 years for males and 29 years for females (p <
0.001). Figure 1 illustrates the patient flow at the EMA.
The patients hospitalized from the EMA comprised 37%
of all hospitalized acute poisonings in Oslo (n = 1069)
(Lund C, Teige B, Drottning P, Stiksrud B, Rui TO, Lyn-
gra M, Ekeberg O, Jacobsen D, Hovda KE: A one year
observational study of all hospitalized and fatal acute
poisonings in Oslo, submitted).
The most frequent main toxic agents were ethanol (n
= 1018; 43%), opioids (n = 519; 22%) and CO/fire
smoke (n = 231; 10%) (Table 2). More than one agent
was taken by 726 patients (31%), and the most common
combination was benzodiazepines and opioids (n = 180;
8%). The most common co-agents were benzodiazepines
(n = 254; 11%), ethanol (n = 218; 9%) and ampheta-
mines (n = 123; 5%).
AOSAs accounted for 1714 (73%) contacts and was
the major intention category in both men and women;
Table 1 Demographic data
Males n
(%)
Females n
(%)
p-value Total n
(%)
Known ID 1125 (97) 694 (99) 0.002* 1819 (98)
Unknown ID 32 (3) 5 (1) 0.002* 37 (2)
Episodes:
1 958 (83) 635 (91) <
0.001*
1593 (86)
2-5 152 (13) 56 (8) <
0.001*
208 (11)
6-22 15 (1) 3 (< 0.5) ns 18 (1)
Age:
16-25 274 (24) 311 (44) <
0.001*
585 (32)
26-35 303 (26) 152 (22) 0.035* 455 (25)
36-45 243 (21) 102 (15) <
0.001*
345 (19)
46-55 173 (15) 69 (10) 0.002* 242 (13)
56-65 89 (8) 33 (5) 0.014* 122 (7)
66-75 33 (3) 15 (2) ns 48 (3)
> 75 15 (1) 13 (2) ns 28 (2)
Unknown 27 (2) 4 (1) 0.004* 31 (2)
Residency:
Oslo 757 (65) 528 (76) <
0.001*
1285 (69)
Outside Oslo 328 (28) 158 (23) 0.007* 486 (26)
Homeless 20 (2) 2 (0) 0.006* 22 (1)
Outside Norway 22 (2) 6 (1) ns 28 (2)
Unknown 30 (3) 5 (1) 0.004* 35 (2)
Total
individuals
1157 (100) 699 (100) 1856 (100)
* Significant
ID: identification
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a possible or definite suicidal intention behind the poi-
soning (Table 3). AOSAs were more common among
men, whereas suicide attempt was more common
among women. Age did not differ significantly between
the intention categories.
On presentation, 1161 (49%) were awake, 1066 (45%)
were drowsy and 120 (5%) were comatose. Complica-
tions developed in 341 (15%) cases. Of these, the most
common were hypothermia (n = 104; 30%), respiratory
depression (n = 71; 21%), hallucinations (n = 57; 17%),
hypotension (n = 34; 10%), hypoglycaemia (n = 21; 6%)
and seizures (n = 19; 6%). No patient had any observed
sequelae. Complications were most frequent in patients
with scopolamine (n = 26/34), cocaine (n = 5/12) or
ecstasy (n = 2/5) as the main toxic agent.
Most patients received no further treatment beyond
observation (n = 2133; 91%). Antidote(s) were given to
203 (9%), activated charcoal to 45 (2%), intravenous
fluids to 18 (1%), anti-emetics/analgesics to nine (0.4%)
and non-invasive mask ventilation to seven (0.3%)
patients. Intubation and gastric decontamination are not
performed at the EMA. One patient required
cardiopulmonary resuscitation and naloxone in the
ambulance but was awake upon arrival at the EMA and
left against medical advice. He was alive one month
later. Of the patients hospitalized from the EMA, 72
(18%) received treatment before hospital admission.
Naloxone was given by the ambulance service or at
the EMA intramuscularly to 123 (5%), intravenously to
16 (1%) and by both routes to 63 (3%) patients. Five
(0.2%) received flumazenil. No other antidotes were
administered. One patient with scopolamine-induced
anti-cholinergic syndrome misdiagnosed as acute drug-
induced psychosis developed hypotension and coma
after treatment with levomepromazine. There were no
other treatment-related complications. The median
observation period was 3.8 hours (inter quartile range
2.1-4.7) for discharged patients.
Four hundred and ten (17%) of the patients assessed
at the EMA were hospitalized (Figure 1). Factors asso-
ciated with hospital admission were GHB or paraceta-
mol as the main toxic agent, a possible or definite
suicidal intention and complications, especially respira-
tory depression and reduced consciousness (Table 4).
Ethanol and opiates were associated with discharge.
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Figure 1 Patient flow in 2348 cases of acute poisoning presenting at the EMA during one year. *Excludes 53 subjects who refused to
participate †29 transferred under paragraph of compulsory observation.
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the EMA without plans for follow-up, and 11% (n =
267) left against medical advice (Figure 1, Table 5). Sui-
cide attempters were most likely to be either hospita-
lized (n = 129; 48%) or referred to psychiatric follow-up
(n = 100; 37%). Patients with an AOSA or other acci-
d e n t a lp o i s o n i n gw e r em o r el i k e l yt ob ed i s c h a r g e d
without follow-up compared with suicide attempters:
OR 22.6 (CI 12.8-39.8) and OR 29.8 (CI 16.4-54.2).
Patients with an AOSA were also more likely to receive
non-psychiatric follow-up or to leave against medical
advice: OR 1.9 (CI 1.3-3.0) and OR 9.0 (CI 3.7-21.9),
respectively.
No patient died at the EMA. Nine patients had fatal
outcomes within one month after their last episode, giv-
ing a one-month mortality rate of 0.6%. Because of repe-
tition in three patients, 14 contacts had fatal outcomes
within one month, resulting in a one-month relative
mortality rate of 0.8% per episode. These three had been
admitted previously for uncomplicated poisonings with
ethanol, benzodiazepines and opioids, and had been dis-
charged without follow-up. The nine patients had a
median age of 31 years (range 25-69) and six (67%)
were male (ns). Five patients died during the first three
days. Of the nine patients, five died of new overdoses (>
2 days after discharge), two died of unrelated causes,
one committed suicide and one may have died of opioid
toxicity recurrence after treatment at the EMA. This lat-
ter patient was found dead in his apartment a few hours
after discharge after treatment with 0.8 mg naloxone
both intramuscularly and intravenously for an AOSA
with heroin (statement from the patient and clinical
signs). He had been observed for four hours, and a
referral letter had been sent to a psychiatric outpatient
clinic. At the autopsy, the cause of death was found to
Table 2 Main and co-agents, main agents separated by sex
Toxic agent Main+co-agents Main agents
n (%) Total n (%) Males n (%) Females n (%) p-value
Ethanol 1236 (53) 1018 (43) 688 (44) 330 (42) ns
Opioids 613 (26) 519 (22) 415 (27) 104 (13) < 0.001*
CO/fire smoke 233 (10) 231 (10) 136 (9) 95 (12) 0.018*
Benzodiazepines 376 (16) 122 (5) 72 (5) 50 (6) ns
Amphetamines 196 (8) 73 (3) 63 (4) 10 (1) < 0.001*
Paracetamol 104 (4) 58 (2) 17 (1) 41 (5) < 0.001*
GHB 58 (2) 54 (2) 39 (3) 15 (2) ns
Antidepressants 54 (2) 39 (2) 10 (1) 29 (4) < 0.001*
Scopolamine 45 (2) 34 (1) 26 (2) 8 (1) ns
Neuroleptics 42 (2) 29 (1) 7 (< 0.5) 22 (3) < 0.001*
Zopiclone/zolpidem 65 (3) 27 (1) 11 (1) 16 (2) 0.011*
Cocaine 32 (1) 12 (1) 10 (1) 2 (< 0.5) ns
NSAIDs 31 (1) 12 (1) 6 (< 0.5) 6 (1) ns
Antihistamines 24 (1) 10 (< 0.5) 2 (< 0.5) 8 (1) 0.004*
Antiepileptics 16 (1) 9 (< 0.5) 3 (< 0.5) 6 (1) ns
Ecstasy 14 (1) 5 (< 0.5) 3 (< 0.5) 2 (< 0.5) ns
Other gases 21 (1) 20 (1) 12 (1) 8 (1) ns
Other 194 (8) 76 (3) 33 (2) 43 (5) < 0.001*
Total cases 2348 (100) 1553 (100) 795 (100)
*Significant
Main agents present in ≤ 5 patients were defined as “other”
NSAIDs: non-steroidal anti-inflammatory drugs
Among the opioids as main agent, 478 were by illegal substances. Among the legal opioids, 19 were by methadone and 14 were by buprenorphine. Among the
cases involving antidepressants as the main agent, 22 were by selective serotonin reuptake inhibitors and five were by tricyclic antidepressants. Among the cases
involving paracetamol as the main agent, 21 were by codeine-combination formulas
Table 3 Physician’s evaluation of intention
Intention Males n
(%)
Females n
(%)
p-value Total n
(%)
AOSA 1259 (81) 455 (57) < 0.001* 1714 (73)
Accident 194 (12) 152 (19) < 0.001* 346 (15)
Possible suicide
attempt
43 (3) 105 (13) < 0.001* 148 (6)
Definite suicide
attempt
46 (3) 76 (10) < 0.001* 122 (5)
Unknown 11 (1) 7 (1) ns 18 (1)
Total cases 1553 (100) 795 (100) 2348
(100)
*Significant
AOSA: accidental overdose with substances of abuse
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death was caused by a new overdose with methadone or
if it initially was an overdose with methadone misinter-
preted as heroin. The patient who committed suicide
had been discharged from the EMA 10 days earlier after
a possible suicide attempt with ethanol and had been
referred to a psychiatric outpatient clinic. There is no
information about whether this patient had received an
appointment. Mortality did not differ significantly
between patients referred to follow-up (5/391; 1.3%) and
those discharged without referral (3/850; 0.4%, p = 0.12)
or those who left against medical advice (1/169; 0.6%, p
= 1.00).
Discussion
The EMA treated more than twice the number of
patients compared with all hospitals in Oslo. Accidental
poisonings with substances of abuse predominated. One
of five patients required hospitalization. The factors
associated with hospitalization were GHB or paraceta-
mol as the main toxic agent, suicidal intention, presence
of complications and reduced consciousness. Almost
half of the patients were discharged without plans for
follow-up. None died at the EMA, and the one-month
mortality was 0.6%.
The large proportion of acute poisoning treated at the
EMA compared with Oslo hospitals is a new and inter-
esting finding. The number of acute poisonings treated
at the EMA in 2008 has more than doubled (146%
increase) since 2003 (956 in 2003 vs. 2348 in 2008) [2].
In the same period, the number of acute poisonings
treated in Oslo hospitals increased by about 10% (947 in
2003 vs. 1069 in 2008) (Lund C, Teige B, Drottning P,
Stiksrud B, Rui TO, Lyngra M, Ekeberg O, Jacobsen D,
Hovda KE: A one year observational study of all hospita-
lized and fatal acute poisonings in Oslo, submitted).
Although the ambulance management denies a shift in
triage pattern, a lower threshold for ambulance transfer
to the EMA is a possible explanation for the increase. If
Table 4 Factors associated with hospitalization, results of
multivariate logistic regression
Crude Adjusted
Total Hospitalized OR 95%
CI
OR 95%
CI
Age (+10 years) 1.0 0.9-1.0 1.1** 1.0-1.2
Sex
Males 1319 237 (18) Ref
Females 689 173 (25) 1.5* 1.2-1.9 1.1 0.8-1.5
Main agents
Other agents 609 188 (31) Ref
Ethanol 859 65 (8) 0.2* 0.1-0.3 0.2* 0.1-0.3
Opioids 437 76 (17) 0.5* 0.3-0.7 0.4* 0.3-0.6
GHB 48 40 (83) 11.2* 5.1-
24.4
12.5* 5.4-
29.3
Paracetamol 55 41 (75) 6.6* 3.5-
12.3
3.8* 1.9-7.6
GCS†
Awake (15) 990 206 (21) Ref
Drowsy (8-14) 908 167 (18) 0.9 0.7-1.1 1.6** 1.2-2.3
Comatose (< 8) 109 37 (34) 2.0** 1.3-3.0 2.3** 1.3-4.3
Complications
Number 1726 299 (17) Ref
Respiratory
depression
61 33 (54) 5.6* 3.3-9.5 7.8* 4.2-
14.4
Others 221 78 (35) 2.6* 1.9-3.5 3.7* 2.5-5.3
Intention
Accidents 334 70 (21) Ref
AOSA 1439 200 (14) 0.6** 0.5-0.8 0.9 0.6-1.4
Possible suicide
attempt
133 70 (53) 4.1* 2.7-6.4 4.5* 2.8-7.3
Definite suicide
attempt
88 59 (67) 7.7* 4.6-
12.9
8.2* 4.7-
14.4
Unknown 14 11 (79) 13.8* 3.8-
50.9
2.8 0.5-
17.2
Total cases 2008 410 (20)
*Significant, p < 0.001, **significant, p < 0.05
AOSA: accidental overdose with substances of abuse
†Glasgow Coma Scale: one case with a missing value
Age was subtracted by 10 in the analysis
Table 5 Odds for different follow-up according to intention; results of univariate logistic regression
Intention Hospitalized Psychiatric Ward Psychiatric Outpatient Clinic Other No referral Left
Suicide attempt 48% 16% 21% 9% 5%† 2%
Reference
AOSA 12% 2% 2% 17% 53% 15%
OR (95% CI) 0.14* (0.1-0.2) 0.08* (0.1-0.1) 0.08* (0.1-0.1) 1.94** (1.3-3.0) 22.59* (12.8-39.8) 8.97* (3.7-21.9)
Accident 20% < 0.5% 3% 13% 60% 3%
OR (95% CI) 0.28* (0.2-0.4) 0.02* (0.0-0.1) 0.11* (0.1-0.2) 1.44 (0.9-2.4) 29.80* (16.4-54.2) 1.74 (0.6-5.1)
Total 17% 3% 4% 15% 48% 11%
*Significant, p < 0.001, **significant, p < 0.05
AOSA: accidental overdose with substances of abuse
Eighteen patients lacked recorded intention and were excluded from the analysis. More than one follow-up is possible for each patient
†One patient with a definite suicide attempt
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Page 7 of 10so, the percentage of patients hospitalized from the
EMA would be expected to have decreased from 2003
to 2008, which was not the case (16% and 17%, respec-
tively). The proportion of patients arriving at the EMA
by ambulance increased by 38%. However, this cannot
explain the 146% increase in poisonings of patients trea-
ted at the EMA. Although other factors, such as
increased availability of illegal drugs, may have increased
somewhat, this would have contributed only to a minor
extent.
Although prescription drugs comprised most poison-
ings in patients treated at the Oslo hospitals, substances
of abuse predominated at the EMA. The main agents
were largely unchanged compared with 2003 apart from
an increase in CO/fire smoke poisonings, which may be
explained by 23% more building/house fires in 2008
[10]. The present male predominance, unchanged from
2003, reflects the higher prevalence of substance abuse
among males [2,11]. In contrast to hospital-treated poi-
sonings, which comprise mainly suicide attempts
[6,12-14], AOSAs predominated at the EMA.
The complication rate was lower in the EMA than in
the Oslo hospitals (18%) and was unchanged from 2003
[2,5]. Combined with the lack of deaths at the EMA,
this finding shows that critically ill patients were hospi-
talized directly, in accordance with the intended patient
flow. The low percentage of comatose patients (13% in
2003 vs. 5% in 2008, p < 0.001) [2] might relate to either
a lower threshold for ambulance transfer to the EMA or
the observed increase in antidote administration on site
by the ambulance service. Interestingly, a larger percen-
tage received naloxone (6% in 2003 vs. 9% in 2008, p =
0.004), although the percentage of poisonings by opioids
remained unchanged.
The factors associated with hospitalization reflect the
policy at the EMA to treat efficiently a large number of
uncomplicated conditions. N-acetylcysteine administra-
tion and intubation are restricted to hospital treatment
because of potential complications. Opioids were asso-
ciated with discharge (83%). A comparison with ambu-
lance data showed large variation in hospitalization
practices for treating opioid poisonings, from 9229/
11336 (81%) refusing transport in an Australian study
[15], to 295/1087 (27%) discharged in an Austrian study
[16]. This variability may reflect a more liberal tradition
to either accept the patient’s wish to be discharged or to
consider further treatment unnecessary.
One positive finding was that few patients with a suici-
dal intention were discharged without follow-up; this is
important because a previous suicide attempt is the
strongest predictor of completing suicide [17,18]. How-
ever, considering the high repetition and mortality rates
in this particular group [3,4,19], it is disturbing that half
of the patients with an AOSA were discharged without
follow-up. A similar low percentage of patient referral
was reported both after hospital treatment of AOSAs in
Oslo (63%) and in a Swiss study of opiate addicts treated
for acute overdose (33%) [20,21]. In most cases, the treat-
ing physician had deemed immediate follow-up unneces-
sary, although in many cases, no suitable options were
available. Although motivation may be a challenge, there
are definite follow-up alternatives in Oslo for overdose
victims without suicidal intent. The most relevant are
outpatient units for substance abusers, social security ser-
vices or visits to general practitioners who have the main
responsibility for coordinating treatment procedures.
Although no patients died at the EMA, one may have
died from methadone toxicity recurrence after discharge.
The lack of laboratory data makes it impossible to
determine whether methadone or heroin was the initial
compound. Because of the long-acting effect of metha-
done (36-48 hours), fatal outcomes have been reported
in hospital several hours after discontinuation of nalox-
one infusion thought to be sufficient [22]. The duration
of naloxone treatment varies between 45 minutes and
four hours, depending on the dose and route of admin-
istration [23]. Our patient had been observed for four
hours without any symptoms. However, naloxone had
been given both intravenously and intramuscularly,
which may have delayed the onset of symptoms. It is
uncertain whether a laboratory test in an emergency
department would have made a difference. A challenge
with many patients is that they wish to leave during
observation because of abstinence and cannot be held
back unless they are actively suicidal, psychotic or
clearly in a life-threatening condition. In 2003, none of
the poisonings treated at the EMA was fatal [2].
The one-month mortality was highest in the first three
days following discharge, and two-thirds of the deaths
were caused by new overdoses, suggesting a target for
preventive initiatives. The mortality did not differ signif-
icantly between patients referred to follow-up and those
not referred, indicating the difficulty in assessing short-
term mortality risk. On the other hand, the study may
indicate that physicians are more concerned about sui-
cide risk than the risk of mortality associated with sub-
stance abuse. However, we do not know how long
patients have to wait for their appointments or whether
they show up. Moreover, data on the effects of different
follow-up treatments on mortality are scarce.
It is debated whether treatment in an outpatient clinic
is preferable to treatment in an emergency department.
Access to a wide range of resources is practical but may
lead to overuse. Laboratory results have limited value in
the clinical setting [24]. Patients brought first to the
EMA and thereafter hospitalized in an ambulance may
present an extra burden on transport resources. The
vast majority, however, were discharged from the EMA
Lund et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012, 20:1
http://www.sjtrem.com/content/20/1/1
Page 8 of 10after a short observation period. According to a World
Health Organization report, the advantages of specialist
treatment are not observed for outpatient care [25].
This report concludes that health care systems with a
strong primary care orientation use services more
appropriately, at lower cost and improve health out-
comes; however, the report also emphasizes the limited
evidence about what can be shifted from specialist-led
secondary care to primary care. In addition, high
volumes of low-acuity patients in emergency depart-
ments may compromise the ability to provide high-qual-
ity emergency care to high-acuity patients because of
overcrowding [26]. A separate outpatient clinic may
reduce waiting times and the number of low-acuity
patients leaving without being seen.
We found no evidence to support the concept that the
limited resources at the EMA may have impaired treat-
ment quality. A low complication rate and low (possibly
zero) mortality indicate that the current practice is safe
and show how low- to intermediate-acuity poisonings
can be treated effectively using limited diagnostic and
treatment resources. However, preventing repetition is
an important aspect that needs to be addressed, and
further studies should focus on whether patients com-
plete their designated follow-up and on the effect of fol-
low-up treatment. Although local health care structures
and poisoning epidemiology affect the generalizability of
the study results, the observation procedure in use at
the EMA may be applicable for practice in rural areas
or as a template for more effective handling of these
patients in hospital emergency departments.
This study has limitations. All physicians at the EMA
assisted in patient inclusion. This was an advantage in
ensuring complete inclusion but may have resulted in a
higher interrater variability for variables such as evalu-
ated intention. Despite the prospective inclusion, cross-
checking of forms against electronic patient lists and
thorough follow-up at the EMA, a few patients may
have been missed. Because of the short observation
time, complications and sequelae may have developed
after discharge and hence may have been missed. An
unknown social security number in 37 patients wea-
kened the one-month mortality analysis. It is debatable
whether both a verification of the toxic agents and an
objective evaluation of intention should have been per-
formed. The clinical practice at the EMA is not based
on laboratory results or structured interviews, and we
based this study on the parameters used in the actual
clinical setting. Further, the limited value of laboratory
results in the clinical setting has been shown [24].
Conclusions
More than twice as many acute poisonings were mana-
ged at the EMA compared with all hospitals in Oslo,
and the median stay was less than four hours. AOSAs
in males predominated. The factors associated with
hospitalization from the EMA were GHB or paraceta-
mol as the main agent, a suicidal intention, respiratory
depression and reduced consciousness. These factors
reflect the current policy at the EMA to treat effec-
tively a large number of uncomplicated conditions.
Only half of the patients were offered follow-up
appointments, and this is probably too low for a
patient group with a high prevalence of substance
abuse, suicidal behaviour and increased long-term
mortality. The large proportion of patients treated but
zero mortality and no sequelae indicate that the treat-
ment at the EMA is safe. These data show that low- to
intermediate-acuity patients can be treated effectively
in a low-resource setting. A current ongoing study at
the EMA focuses on whether patients continue with
their designated follow-up and the effects of this fol-
low-up treatment.
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